Ballerup, Denmark (ots/PRNewswire) - Data presented in a Late Breaking Science session at the 74th Annual Meeting of the American Academy of Dermatology (AAD) in Washington, D.C. demonstrate that calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g) foam formulation is a stable supersaturated solution ...
Chertsey, England (ots/PRNewswire) - Astellas Pharma Europe Ltd., a subsidiary of Astellas Pharma Inc. (TSE:4503), is pleased to announce that Mr Yukio Matsui has been appointed as President of EMEA Operations, with responsibility for the company's commercial operations in Europe, the Middle East and Africa. Yukio will assume his new position on 1st April 2016. Since ...
Lausanne, Switzerland (ots/PRNewswire) - Debiopharm International SA (Debiopharm), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company today announces that the Tokyo District Court granted Debiopharm an overall victory for the first instance demanding the suspension of patent infringement of ...
Shire Pharmaceuticals Group Plc
Dublin (ots/PRNewswire) - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") reminds shareholders of important developments relating to the Company's Income Access Share arrangements ("IAS Arrangements"). All shareholders who wish to receive, or continue to receive, UK sourced dividends via the IAS Arrangements (and ...
Hitachi Medical Systems Europe Holding AG
Hitachi Medical Systems Europe Holding AG
Glasgow, Scotland (ots/PRNewswire) - This material is intended for European and UK medical media only. For journalistic assessment and preparation before publication. New findings show that Xultophy® (insulin degludec/liraglutide; IDegLira), the first once-daily combination of a long-acting basal insulin ...
Paris and London (ots/PRNewswire) - New Agreement Provides Healthcare Professionals with Streamlined, Cost-Effective Options for Accessing the CyberKnife® and TomoTherapy® Systems Accuray Europe and GE Capital Healthcare Equipment Finance announced today they have signed a collaboration agreement to develop ...
London (ots/PRNewswire) - ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today presented positive results from the 41 week phase IIa ECLAIR study, which evaluated the safety, tolerability, dosing and satisfaction with the ...
Astellas Pharma Europe Limited
Chertsey, England (ots/PRNewswire) - Experts say the knock-on effect of lack of planning for later life, as highlighted in poll conducted for this year's ASTELLAS INNOVATION DEBATE[TM],will further impact upon stretched NHS resources Results from a new survey for the annual Astellas Innovation Debate have ...
London (ots/PRNewswire) - 32 week maintenance data presented at CROI showed comparable viral suppression rates between injectable regimen and three drug oral regimen ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today presented ...
Cork, Ireland (ots/PRNewswire) - Intramuscular 2-drug maintenance therapy demonstrates comparable antiviral activity to daily oral 3-drug combination Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, (Janssen) announced 32-week data from an ongoing phase IIb study. A ...
London (ots/PRNewswire) - GlaxoSmithKline plc (LSE: GSK) today announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, has completed two previously announced transactions with Bristol-Myers Squibb to acquire its late-stage HIV ...
Lyon, France (ots/PRNewswire) - Results of review-based evidence on the public healthvalue of vaccination for seniors in Europe presented at WAidid congress The first Biennial Congress of the World Association for Infectious Diseases and Immunological Disorders (WAidid), has been held in Milan on February 18-20, ...
Lyon, France (ots/PRNewswire) - This decision opens the way to making Vaxelis® available to infants and toddlers in European countries Sanofi Pasteur MSD announced today that the European Commission has granted the marketing authorization for Vaxelis®, a new fully-liquid hexavalent vaccine indicated for primary and booster vaccination of infants and toddlers from the ...
Tokyo (ots/PRNewswire) - Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that its European subsidiary, Daiichi Sankyo Europe GmbH Group (headquartered in Munich, Germany; hereafter, DSE), has granted exclusive rights to Merck & Co, Inc., Kenilworth, NJ, USA (NYSE: MRK), known as MSD outside the US and Canada (hereafter, MSD) to market the oral, once-daily anti-coagulant, LIXIANA® (edoxaban), ...
Sunnyvale, California (ots/PRNewswire) - Accuray Conference Focused on Trends in Radiation Oncology Accuray Incorporated (NASDAQ: ARAY) announced today highlights from their European AERO(TM) (Accuray Exchange in Radiation Oncology) Academy conference hosted in Paris, France on February 5th and 6th. (Logo: http://photos.prnewswire.com/prnh/20151126/291246LOGO ) (Photo: http://photos.prnewswire.com/prnh/20160108/320402 ) ...
Shire Pharmaceuticals Group Plc
Lexington, Massachusetts (ots/PRNewswire) - This press release is intended for U.S. and EU audiences only. A separate press release has been prepared for use in Japan. With submission, Shire continues to strengthen its presence in Japan Shire plc (LSE: SHP, NASDAQ: SHPG) and Shionogi & Co., Ltd. recently announced that Shionogi submitted a New Drug Application (NDA) ...
Chertsey, England (ots/PRNewswire) - Poll conducted in advance of this year's ASTELLAS INNOVATION DEBATE(TM) also demonstrates public are open to an additional 'health tax' to support improved NHS services, but clinicians fear additional charges will hit the poorest hardest Although the NHS is ranked as one of the ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK and U.S. based media - The Fertility Leader Merck receives market authorization from EMA for its advanced GONAL-f® prefilled pen for improved ease-of-use - Patients, nurses and doctors help to innovate and improve the design of a product which has already helped bring over two million babies into the world[1] Merck, a leading science and technology company, today ...
Munich (ots/PRNewswire) - Daiichi Sankyo Europe GmbH (hereafter, Daiichi Sankyo) today announced that the German public health agency, The Federal Joint Committee (Gemeinsamer Bundesausschuss - G-BA), has granted an indication of a minor additional benefit for LIXIANA® (edoxaban), an oral, once-daily selective ...
Mönchengladbach, Germany (ots/PRNewswire) - The HOYA Vision Care Company, a key player in the global market for ophthalmic lenses, presents Hoya EyeGenius, an innovative high-precision measurement system for the quick and easy measurement and correction of fixation disparities. The digital era demands a lot from our binocular vision and can cause visual stress. In the case of heterophoria, this may lead to fixation disparity. Hoya EyeGenius was developed in close ...
Sunnyvale, California (ots/PRNewswire) - Premier Qatar, Latvian Cancer Centers to Offer Patients Treatment with the CyberKnife® System; Leading Bulgarian Hospital to Provide Treatment with the TomoTherapy® System Accuray Incorporated (NASDAQ: ARAY) announced today that the first centers in Qatar, Latvia, and Bulgaria are now equipped with its radiation therapy ...
Lausanne, Switzerland (ots/PRNewswire) - Debiopharm International SA (Debiopharm), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company, today announced a collaboration in order to supply triptorelin pamoate 3.75 mg 1-month formulation for patients suffering from salivary gland cancer ...
Lugano, Switzerland (ots/PRNewswire) - ~ 40 years helping patients achieve a better quality of life ~ Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, is delighted to launch its 40th anniversary celebrations in San Francisco, US, at the time of the JP Morgan 34th Annual Healthcare Conference. Helsinn believes its core values of respect, integrity and quality have underpinned four decades of ...
London (ots/PRNewswire) - ViiV Healthcare, a global specialist HIV company with GSK, Pfizer Inc. and Shionogi Limited as shareholders, today formalised its collaboration with Janssen Sciences Ireland UC (Janssen) for the phase III investigation and commercialisation of the long-acting, injectable formulations of ...
Cork, Ireland (ots/PRNewswire) - Results from ongoing phase IIb Week 32 study show that if successfully developed and approved, people living with HIV could potentially maintain viral suppression Janssen Sciences Ireland UC (Janssen), today formalized its collaboration with ViiV Healthcare on phase III development ...
Heidelberg (ots) - BioMed X Innovation Center announced today that they have entered into a collaboration agreement with Johnson & Johnson Consumer, Inc. seeking to establish a research group to focus on the development of novel methods for the disruption of oral biofilms. This collaboration was facilitated by ...
Darmstadt, Germany (ots/PRNewswire) - - Merck becomes first pharmaceutical company to collaborate with multiple diagnostic providers to support RAS biomarker testing - Collaboration allows Merck to provide complementary molecular testing solutions to various laboratory segments - Biocartis' fully automated Idylla(TM) system will enable more clinics to assess RAS ...
Uithoorn, The Netherlands (ots/PRNewswire) - HOYA Vision Care Company, a key player in the global market for ophthalmic lenses, announces the establishment of HOYA Lens RUS LLC. Building on a strong position in the Russian Federation through a longtime local distributor, HOYA is now entering the market directly to provide better service and further develop its customer base. HOYA sees significant opportunities to expand ...